Advisory Alpha’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,005
| Closed | -$22.2K | – | 342 |
|
|
2023
Q1 | $22.2K | Hold |
12,005
| – | – | ﹤0.01% | 279 |
|
|
2022
Q4 | $13.3K | Hold |
12,005
| – | – | ﹤0.01% | 260 |
|
|
2022
Q3 | $28K | Hold |
12,005
| – | – | ﹤0.01% | 239 |
|
|
2022
Q2 | $36K | Hold |
12,005
| – | – | ﹤0.01% | 245 |
|
|
2022
Q1 | $82K | Hold |
12,005
| – | – | 0.01% | 264 |
|
|
2021
Q4 | $100K | Hold |
12,005
| – | – | 0.01% | 258 |
|
|
2021
Q3 | $89K | Hold |
12,005
| – | – | 0.01% | 237 |
|
|
2021
Q2 | $82K | Buy |
+12,005
| New | +$82K | 0.01% | 188 |
|